These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 16507052

  • 21. Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment.
    Schulman CC.
    Urology; 2003 Sep; 62(3 Suppl 1):24-33. PubMed ID: 12957197
    [Abstract] [Full Text] [Related]

  • 22. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F, Oelke M, Jungwirth A, Hatzimouratidis K, Watts S, Cox D, Viktrup L.
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.
    Barqawi AB, Myers JB, O'Donnell C, Crawford ED.
    BJU Int; 2007 Oct; 100(4):853-7. PubMed ID: 17662074
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects.
    La Vignera S, Aversa A, Cannarella R, Condorelli RA, Duca Y, Russo GI, Calogero AE.
    Expert Opin Pharmacother; 2021 Feb; 22(2):179-189. PubMed ID: 32902360
    [Abstract] [Full Text] [Related]

  • 27. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ, Miner M.
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [Abstract] [Full Text] [Related]

  • 28. Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study.
    Hellstrom WJ, Sikka SC.
    J Androl; 2009 Jan; 30(4):469-74. PubMed ID: 19201696
    [Abstract] [Full Text] [Related]

  • 29. The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Fitzpatrick JM, Desgrandchamps F.
    BJU Int; 2005 Mar; 95(4):575-9. PubMed ID: 15705083
    [Abstract] [Full Text] [Related]

  • 30. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
    van Moorselaar RJ, Hartung R, Emberton M, Harving N, Matzkin H, Elhilali M, Alcaraz A, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2005 Mar; 95(4):603-8. PubMed ID: 15705088
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC, Elhilali M, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia.
    Homma Y, Kawabe K, Takeda M, Yoshida M.
    Urology; 2010 Dec; 76(6):1446-50. PubMed ID: 20472263
    [Abstract] [Full Text] [Related]

  • 37. BPH: epidemiology and comorbidities.
    McVary KT.
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S122-8. PubMed ID: 16613526
    [Abstract] [Full Text] [Related]

  • 38. Lower urinary tract symptoms and sexual dysfunction: a common approach.
    Giuliano F.
    BJU Int; 2008 Mar; 101 Suppl 3():22-6. PubMed ID: 18307682
    [Abstract] [Full Text] [Related]

  • 39. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
    Rosen RC.
    Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
    [Abstract] [Full Text] [Related]

  • 40. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
    Roehrborn CG, Siami P, Barkin J, Damião R, Becher E, Miñana B, Mirone V, Castro R, Wilson T, Montorsi F, CombAT Study Group.
    Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.